News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sarepta Therapeutics (SRPT) Should Shut Up About Ebola And Focus On Job No. 1



8/7/2014 6:48:14 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

By publicizing its outreach to the U.S. government about an experimental ebola treatment, Sarepta comes off looking like just another opportunistic, self-promoting drug developer. Sarepta isn't wrong to remind the U.S. government about the drug in its freezer which might be effective against the ebola virus, but why talk to the media about it?

Hey, check out all the research scientist jobs. Post your resume today!

Read at The Street.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES